Its called reality. Im also a shareholder, and a healthcare professional. I can see the potential as Ive referred patients onto gut microbiome tests. The reality is that gut microbiome test is the domain of naturopaths, and most doctors think naturopaths are quacks. There are many doctors who think IBS is not a diagnosis, so as a mainstay of healthcare, its part of the ancillary group of practises, an outlier.
The opportunity is not in tests for the general pop for these guys, its in another space. I'll leave you to figure out what that is.
And good afternoon to you too, sir.
Its called reality. Im also a shareholder, and a healthcare...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.015(8.82%) |
Mkt cap ! $82.85M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.5¢ | 17.0¢ | $112.8K | 658.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9107 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 15.53pm 22/08/2024 (20 minute delay) ? |
| MAP (ASX) Chart |